By Type (Assays, Devices, Consumables), Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), Deployment (Automated, Manual), End User (Hospitals, Clinics, Diagnostic Laboratories, Academic Institutes, Others), Distribution Channel (Direct, Indirect), Country (Germany, France, Italy, U.K., Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe), Market Trends and Forecast to 2027
Market Analysis and Insights: Europe Diabetic Assays Market
Europe diabetic assays market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with the CAGR of 3.9% in the forecast period of 2020 to 2027and expected to reach USD 1,184.48 million by 2027 from USD 883.60 million in 2019. Growing prevalence of diabetes and high diabetes reimbursement of diabetes are the factors for the market growth.
Diabetes products cost has increased by 26% from 2012 to 2017 after taking into consideration various factor such as economic and inflation factors. This is accredited to the increasing prevalence of diabetes and per person cost due to these reasons government in various countries has established government and non-organization to help patients in diabetes management.
Growing government awareness towards the identification of diabetes among geriatric and young population and high reimbursement policies services provided by the government and private organizations are accelerating the population towards the diagnosis of diabetes and focusing towards their treatment.